Along with other inflammatory genes, signaling between NFκB and its regulators during inflammation [6,16–18] and cancer [7,19] has been the subject of close study, but neither the full repertoire of molecular players nor their mechanisms of interaction have been fully specified. This evidence concerns the gene NFKB1 and cancer.